Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2024-11-05 | “Dr. Almenoff ... led the development of pioneering data analytics systems ... Dr. Almenoff has strong expertise in translational medicine, clinical development, commercial strategy, and business development ...” |
Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-04-09